BCTX

Briacell Therapeutics
BCTX

Overview Fund Activity

22 hedge funds and large institutions have $14.8M invested in Briacell Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
8
Reduced
4
Closed
1
Calls
$4.6M
Puts
$243K
Net Calls
+$4.36M
Net Calls Change
+$414K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$203K
2
OBWG
Onyx Bridge Wealth Group
New York
+$176K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$97.1K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$87.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$87.5K

Top Sellers

1
WA
Wasatch Advisors
Utah
-$1.44M
2
N
Natixis
France
-$427K
3
KPF
K2 Principal Fund
Ontario, Canada
-$156K
4
RAM
Redmond Asset Management
Virginia
-$25.5K
5
LCM
Lynwood Capital Management
Ontario, Canada
-$10.5K
Name Holding Trade Value Shares
Change 		Shares
Change %
KPF
26
K2 Principal Fund
Ontario, Canada
– -$156K -166 Closed
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
– -$206 – –
1
2